Listen: Covid-19's U.S. surge & GSK's mystery whistleblower

Listen: Covid-19's U.S. surge & GSK's mystery whistleblower

Is this a second wave or a rising tide? 

Who’s the real GlaxoSmithKline whistleblower? And what happens to cancer care in a pandemic? We discuss all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. 

First, we talk about the alarming spike in Covid-19 cases in states across the South and West. Then, we’re joined by David Barboza of The Wire to detail the latest revelations in GlaxoSmithKline’s salacious bribery scandal. Finally, STAT’s Elizabeth Cooney dials in to discuss how cancer doctors are adapting to the pandemic when it comes to patient care and clinical trials.

Listen here.